Trial intelligence / Profile preview

ABC-PICU: RBC storage duration in critically ill children

NCT01977547Phase 3Completed

Sponsor
Washington University School of Medicine
Start
Jan 2014
Primary completion
Dec 2018
Modality
Recombinant Proteins and Enzymes, Cell Therapies
Countries
5
01

Overview

Phase 3, randomised, double-blind trial of red blood cells in anemia (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: New or Progressive Multiple Organ Dysfunction Syndrome at 28 days. Started Jan 2014; status: completed.

02

Drugs

red blood cells
03

Conditions

anemia

Beyond the preview

Go deeper on NCT01977547.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01977547.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call